Pillsbury Winthrop Shaw Pittman LLP advised Invitae on the deal. Leading medical genetics company Invitae announced the sale of Research Use Only (RUO) kitted solutions by Integrated...
You must be a Standard 1 Year member to access this content.
Perkins Coie advised PURO Lighting, LLC and LED Supply Co. LLC on the deal. PURO Lighting, LLC and LED Supply Co. LLC announced their acquisition by Applied...
You must be a Standard 1 Year member to access this content.
Paul Hastings LLP advised Operadora de Servicios Mega, S.A. de C.V., SOFOM, E.R. on the deal. Cleary Gottlieb has advised Goldman Sachs & Co. and HSBC...
You must be a Standard 1 Year member to access this content.
Paul Hastings LLP advised J.P. Morgan, BNPP, Barclays, BofA, Citi, Crédit Agricole, Credit Suisse, Deutsche Bank, Goldman Sachs, Morgan Stanley, Royal Bank of Canada, TD Securities,...
You must be a Standard 1 Year member to access this content.
Paul Hastings LLP advised 2U on the deal. 2U (Nasdaq: TWOU), a leading online education platform company, announced the refinancing of its term loan, which includes extending...
You must be a Standard 1 Year member to access this content.
Paul Hastings LLP advised Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein (Einstein) on the deal. Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein (Einstein) announced a New York...
You must be a Standard 1 Year member to access this content.
Paul Hastings LLP advised Wuxi Nengda Thermoelectricity Co. on the deal. Wuxi Nengda Thermoelectricity Co., Ltd., a state-owned enterprise in Wuxi City, Jiangsu Province, PRC, acted...
You must be a Standard 1 Year member to access this content.
Paul Hastings LLP advised Vector Capital on the deal. Progress (NASDAQ: PRGS), the trusted provider of application development and infrastructure software, announced it has entered into...
You must be a Standard 1 Year member to access this content.
Orrick advised Bridging Pennsylvania Developer I on the deal. Mayer Brown advised the underwriters for the issuance of approximately $1.8 billion. Bridging Pennsylvania Developer I, a...
You must be a Standard 1 Year member to access this content.
Orrick advised Catalyst Biosciences, Inc. on the deal. South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. announced its acquisition of the F351 program, a next-generation fibrosis drug,...
You must be a Standard 1 Year member to access this content.
Orrick advised the Metropolitan Transportation Authority (MTA) on the deal. The Metropolitan Transportation Authority (MTA) announced its historic US$965.2 million subway station accessibility P3 to upgrade...
You must be a Standard 1 Year member to access this content.
Orrick and Cirio advised Ipsen on the deal, while Paul, Weiss, Rifkind, Wharton & Garrison and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Albireo. Ipsen...
You must be a Standard 1 Year member to access this content.
